Atlas Trials

The Effectivity and Safety of Favipiravir Compared to Oseltamivir as Adjuvant Therapy for COVID-19

Clinical trial NCT04558463 · UNKNOWN

Trial details

NCT number
NCT04558463
Sponsor
Indonesia University
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Covid19
Start date
2020-04-16
Primary completion
2020-09-30
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.